Article
The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
Metabolism: clinical and experimental - 1 Feb 1990
O'Malley J P, Illingworth D R
Abstract excerpt
Apolipoprotein E (apo E) phenotypes have been previously shown to influence plasma lipoprotein concentrations in normal populations and to affect the response to some lipid lowering drugs. The purpose of the present study was to determine if variations in the apo E phenotype also affect basal lip...
Topics
- Adult
- Aged
- Apolipoproteins E
- Cholesterol, HDL
- Cholesterol, LDL
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Heterozygote
- Humans
- Hyperlipoproteinemia Type II
- Lipids
